Patent · US Active

Compositions comprising 15-HEPE and methods of using the same

US10813903B2 · kind B2 · utility

0Cited by

6References

24Claims

0Family size

Assignee

Afimmune Limited · IE

Inventors

Jonathan Rowe · Waterford, US
Kevin Duffy · Collegeville, US
John Climax · Dublin, IE

Key dates

Filing date	Jul 31, 2019
Grant date	Oct 27, 2020
Priority date	—
Expiry date	Jul 31, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P1/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the compositions, formulations and methods of treating fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) and their sequelae by administration of 15-OHEPA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.